IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atlas Venture Associates IX, LLC

Q2 2018 Holdings

Filed 2018-07-31 | 7 holdings | $227.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Surface Oncology IncCOM86877M209$75.8K4,645,45333.3%
Intellia Therapeutics Inc(NTLA)COM45826J105$50.3K1,836,81022.1%
Unum Therapeutics IncCOM903214104$48.2K3,361,53521.2%
Synlogic IncCOM87166L100$26.1K2,651,96311.5%
Spero Therapeutics Inc(SPRO)COM84833T103$20.2K1,376,9688.9%
Carbon Black IncCOM14081R103$4.7K181,2732.1%
Snap Inc(SNAP)CL A83304A106$2.0K150,1600.9%